471 related articles for article (PubMed ID: 15520626)
1. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature.
Tierney EP; Badger J
MedGenMed; 2004 Sep; 6(3):4. PubMed ID: 15520626
[TBL] [Abstract][Full Text] [Related]
2. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
3. [Necrolytic migratory erythema].
Dandrifosse JF; Dandrifosse AC; Piérard G; Scheen AJ; Dandrifosse G
Rev Med Liege; 1998 Dec; 53(12):778-83. PubMed ID: 9927878
[TBL] [Abstract][Full Text] [Related]
4. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
5. Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene.
Tamura A; Ogasawara T; Fujii Y; Kaneko H; Nakayama A; Higuchi S; Hashimoto N; Miyabayashi Y; Fujimoto M; Komai E; Kono T; Sakuma I; Nagano H; Suzuki S; Koide H; Yokote K; Iseki K; Oguma R; Matsue H; Nojima H; Sugiura K; Yoshitomi H; Ohtsuka M; Rahmutulla B; Kaneda A; Inoshita N; Ogawa S; Tanaka T
J Clin Endocrinol Metab; 2018 Jul; 103(7):2417-2423. PubMed ID: 29688432
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
Mullans EA; Cohen PR
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):866-73. PubMed ID: 9591806
[TBL] [Abstract][Full Text] [Related]
7. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
[TBL] [Abstract][Full Text] [Related]
8. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
Siegel R; Linse R; Rau B
Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
[TBL] [Abstract][Full Text] [Related]
9. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome.
Alexander EK; Robinson M; Staniec M; Dluhy RG
Clin Endocrinol (Oxf); 2002 Dec; 57(6):827-31. PubMed ID: 12460334
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
Oberkirchner U; Linder KE; Zadrozny L; Olivry T
Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
[TBL] [Abstract][Full Text] [Related]
11. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
12. Necrolytic migratory erythema: a report of three cases.
Thorisdottir K; Camisa C; Tomecki KJ; Bergfeld WF
J Am Acad Dermatol; 1994 Feb; 30(2 Pt 2):324-9. PubMed ID: 8294591
[TBL] [Abstract][Full Text] [Related]
13. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
Wu SL; Bai JG; Xu J; Ma QY; Wu Z
World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
[TBL] [Abstract][Full Text] [Related]
14. Necrolytic migratory erythema: case report and clinical review.
Adam DN; Cohen PD; Ghazarian D
J Cutan Med Surg; 2003; 7(4):333-8. PubMed ID: 14738101
[TBL] [Abstract][Full Text] [Related]
15. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
Technau K; Renkl A; Norgauer J; Ziemer M
Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
[TBL] [Abstract][Full Text] [Related]
16. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
[TBL] [Abstract][Full Text] [Related]
17. Necrolytic migratory erythema associated with a glucagon-producing primary hepatic neuroendocrine carcinoma in a cat.
Asakawa MG; Cullen JM; Linder KE
Vet Dermatol; 2013 Aug; 24(4):466-9, e109-10. PubMed ID: 23738981
[TBL] [Abstract][Full Text] [Related]
18. Necrolytic migratory erythema without glucagonoma in a patient with short bowel syndrome.
Nakashima H; Komine M; Sasaki K; Mitsui H; Fujimoto M; Ihn H; Asahina A; Kikuchi K; Tamaki K
J Dermatol; 2006 Aug; 33(8):557-62. PubMed ID: 16923138
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema.
Bewley AP; Ross JS; Bunker CB; Staughton RC
Br J Dermatol; 1996 Jun; 134(6):1101-4. PubMed ID: 8763433
[TBL] [Abstract][Full Text] [Related]
20. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
Kasper CS
Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
